In memory of a legendary athlete: measured success in diabetic nephropathy.
Historically diabetic nephropathy has been a devastating complication of both type I and type II diabetes. The past 2 decades have seen enormous conceptual advances in understanding the pathogenesis of diabetic nephropathy. The genetic determinants of diabetic renal disease have also been elucidated as well as biochemical events and cytokine interactions. Most importantly, key clinical trials have identified therapeutic interventions which can slow or halt the progression of diabetic nephropathy, specifically the therapeutic use of angiotensin-converting enzyme inhibition and intensive blood sugar control. Multiple treatment modalities for patients once they reach end-stage renal disease are also available and great strides have been improving outcomes in these areas as well.
Division of Nephrology, Vanderbilt University Medical Center, Nashville, TN, USA. julia.lewis@mcmail.vanderbilt.edu
J
J
Lewis
E J
EJ
Lewis
D001484:Baseball / Q000266:history; D003928:Diabetic Nephropathies / Q000235:genetics / Q000266:history* / Q000628:therapy; D005197:Famous Persons; D049673:History, 20th Century; D006801:Humans; D008297:Male